EU | pharmaphorum

EU

News

Pfizer's Omicron BA.4/BA.5 vaccine recommended by CHMP

Pfizer and BioNTech's COVID-19 vaccine targeting Omicron BA.4 and BA.5 has been recommended for authorisation by the EMA's human medicines committee, shortly after the panel gave its blessi

News

Illumina eyeing future of Grail as EU shoots down merger

The EU has blocked the merger of Illumina and Grail, saying the deal would stifle innovation in blood-based diagnostics for cancer diagnostics, just days after a bid by the US authorities t

News

Life science leaders sign new ‘Biotech Social Pact’ for Europe

EMA panel backs COVID-19 vaccines targeting Omicron BA.1

The EMA's human medicines committee (CHMP) has recommended authorisation of two COVID-19 vaccines from Moderna and Pfizer/BioNTech that include sequences coding for Omicron spike protein as

News

Roctavian okay sets up another gene therapy test for Europe

BioMarin Pharma has its landmark first approval for Roctavian – the first for a haemophilia gene therapy – and will now have to see if that can convert that into a viable business in Europe

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J gets first approval for multiple myeloma bispecific Tecv...

Johnson & Johnson has its first worldwide regulatory approval – in the EU – for Tecvayli, one of two much-anticipated bispecific antibodies the drugmaker has developed for patients with

News

Oncopeptides gets EU nod for myeloma drug Pepaxti ahead of U...

The European Commission has approved Oncopeptides' Pepaxti in combination with dexamethasone for multiple myeloma patients with so-called triple class refractory disease – in other words th

Pfizer's Omicron BA.4/BA.5 vaccine recommended by CHMP

Illumina eyeing future of Grail as EU shoots down merger

EMA panel backs COVID-19 vaccines targeting Omicron BA.1

Roctavian okay sets up another gene therapy test for Europe

J&J gets first approval for multiple myeloma bispecific Tecv...

Oncopeptides gets EU nod for myeloma drug Pepaxti ahead of U...

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

EU

Editor's Picks